Altimmune (ALT) EBITDA Margin Growth (5y) (2015 - 2025)
Altimmune (ALT) EBITDA Margin Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Altimmune | 364.05 Mn | 364.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.07 Mn |
| Sep 30, 2025 | -41.66 Mn |
| Jun 30, 2025 | -45.80 Mn |
| Mar 31, 2025 | -43.60 Mn |
| Dec 31, 2024 | -49.66 Mn |
| Sep 30, 2024 | -49.36 Mn |
| Jun 30, 2024 | -53.47 Mn |
| Mar 31, 2024 | -53.58 Mn |
| Dec 31, 2023 | -8.98 Mn |
| Sep 30, 2023 | -607,248.00 |
| Jun 30, 2023 | -29.99 Mn |
| Mar 31, 2023 | -10.34 Mn |
| Dec 31, 2022 | -8.81 Mn |
| Sep 30, 2022 | -123.69 Mn |
| Jun 30, 2022 | -25.48 Mn |
| Mar 31, 2022 | -5.94 Mn |
| Dec 31, 2021 | -23,946.00 |
| Sep 30, 2021 | -2.05 Mn |
| Jun 30, 2021 | -1.79 Mn |
| Mar 31, 2021 | -164,866.00 |